Vericel Stock

Vericel PEG

The PEG Ratio (Price/Earnings-to-Growth) of Vericel (VCEL) as of Aug 16, 2026 is 2.31. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 0.53 — a change of 336.99% (higher).

PEG

2.31

YoY

336.99%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Vericel is 2026 2.31 . PEG Ratio (Price/Earnings-to-Growth) of Vericel was 2025 0.53 . It decreases by 336.99% higher compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

PEG Ratio (Price/Earnings-to-Growth) of Vericel is 2.31 in 2026.

PEG Ratio (Price/Earnings-to-Growth) of Vericel changed from 0.53 to 2.31, representing a 336.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Vericel since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Vericel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vericel

All Key Metrics — Vericel